Cargando…
T Stage and Pretreatment Standardized Uptake Values Predict Tumor Recurrence With 5-Fraction SABR in Early-Stage Non-Small Cell Lung Cancer
PURPOSE: Five-fraction stereotactic ablative radiotherapy (SABR) regimens are frequently used to treat centrally located early-stage non-small cell lung cancer or disease in the proximity of the chest wall as a means of optimizing tumor control and reducing treatment toxicity. However, increasing th...
Autores principales: | Hsu, Eric J., Mendel, Jameson T., Ward, Kristin A., El-Ashmawy, Mariam, Lee, Minjae, Choy, Hak, Westover, Kenneth D., Vo, Dat T., Timmerman, Robert D., Sher, David J., Iyengar, Puneeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486424/ https://www.ncbi.nlm.nih.gov/pubmed/36148376 http://dx.doi.org/10.1016/j.adro.2022.100995 |
Ejemplares similares
-
Stereotactic ablative body radiation therapy for tumors in the lung in octogenarians: a retrospective single institution study
por: Cannon, Nathan A, et al.
Publicado: (2014) -
Clinical Factors That Affect Fiducial Tracking in Robotic SABR for Lung Tumors
por: Huynh, Duy, et al.
Publicado: (2023) -
Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC?
por: Brooks, Eric D., et al.
Publicado: (2019) -
Efficacy and Safety of Stereotactic Body Radiation Therapy for Pediatric Malignancies: The LITE-SABR Systematic Review and Meta-Analysis
por: Singh, Raj, et al.
Publicado: (2023) -
Interval From Simulation Imaging to Treatment Delivery in SABR of Lung Lesions: How Long is Too Long for the Lung?
por: Colin, Gilles, et al.
Publicado: (2022)